Community curated by people like you

Rapamycin for Longevity stories

Sep 24, 2025

Clinical Evidence for Off-Label Rapamycin as a Longevity Drug Remains Limited

A review of clinical evidence finds insufficient data to confirm or deny longevity benefits of low-dose rapamycin in healthy adults.

Sep 24, 2025·4 sources

00

Top claims

▪Animal studies have shown promising results for rapamycin extending lifespan, but human evidence remains insufficient
▪The PEARL trial found low-dose intermittent rapamycin over 48 weeks was relatively safe and improved lean tissue mass and pain in women
▪The lack of human clinical evidence means rapamycin should not be used off-label for anti-aging until larger trials are completed

Subtopics

Lifestyle, Wellness and Nutrition1 Longevity & biohacking1

Related timelines

Congress

Trump administration

US midterm elections

Iran War

Russia-Ukraine war